Corbus Pharmaceuticals Holdings, Inc., announced it will soon begin a Phase 2 clinical trial to test the efficacy, safety, tolerability, and biologic…
Ines Martins, PhD
Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ines Martins, PhD
Aurinia Pharmaceuticals recently announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to voclosporin, a next-generation calcineurin…
Immunovia AB recently announced it has entered into a collaboration with a large multinational life science company to jointly…
The Lupus Foundation of America announced that its 2016 peer-reviewed research funding will include a focus on lupus studies into…
How often should you exercise when you have lupus? Research has shown that lupus patients are strong believers in the…
As a celebration for its 37th anniversary of independence, St. Lucia Arthritis and Lupus Association (SLALA) reflects on the journey so many…
Ulster University researchers found that mercury exposure through dental fillings or the consumption of seafood does not exacerbate…
Temple University School of Medicine researchers have discovered how infections cause lupus flares. In a study funded by the Lupus…
Immunovia AB, together with Lund University in Sweden, will launch a new program to develop, validate, and commercialize antibody array-based…
Systemic lupus erythematosus (SLE) patients with chronic renal failure who are using anticoagulants or antiepileptics are at higher risk for osteoporosis and…